Logue, J.

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

Parker, C., Nilsson, S., Heinrich, D., Helle, S. I., O'Sullivan, J. M., Fosså, S. D., Chodacki, A., Wiechno, P., Logue, J., Seke, M., et al. (2013) · New England Journal of Medicine

Prostate Cancer Treatment and ResearchBone health and treatments

Cited by 3,408

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Dearnaley, D., Syndikus, I., Mossop, H., Khoo, V., Birtle, A., Bloomfield, D., Graham, J., Kirkbride, P., Logue, J., Malik, Z., et al. (2016) · The Lancet Oncology

Prostate Cancer Diagnosis and TreatmentAdvanced Radiotherapy Techniques

Cited by 1,339

Randomized controlled trial to assess the effectiveness of a videotape about radiotherapy

Harrison, R., Dey, P., Slevin, N. J., Eardley, A., Gibbs, A., Cowan, R., Logue, J. P., Leidecker, V, & Hopwood, P. (2001) · British Journal of Cancer

Patient-Provider Communication in HealthcareCancer survivorship and care

Cited by 28